Sarcomas of the jaws (JS) are infrequent, accounting for about 1% of
all the malignant tumors that occur in the oral and maxillofacial region.
These sarcomas are highly aggressive and as such require an accurate diagnosis and therapy to be treated effectively.
Prognostic factors for sarcomas are not well-known, specifically regarding the jawbones. There are some studies that present data on osteosarcomas of the jawbones or data on head and neck sarcomas, but these studies are far from comprehensive.
Studies such as that by Patel et al. reviewed the records of 44 patients with osteogenic head and neck sarcomas and found, at 3 and 5 years, overall survival rates of 81% and 70%, respectively.
In this study, only the surgical margins were correlated significantly to survival prognosis.
